Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sunrun Inc (RUN) vs Tenet Healthcare Corporation (THC) Price & Performance

Sunrun IncTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Sunrun Inc vs Tenet Healthcare Corporation — how do they compare? Sunrun Inc trades at $7.62 (market cap $1.83B), while Tenet Healthcare Corporation trades at $261.27 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 11.5× Sunrun Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sunrun Inc for 16 Days and Tenet Healthcare Corporation for 15 Days on average.

RUNTHC
Market Cap
$1.83B$20.98B
Volume
8,672,852428,008
Sector
EnergyHealth
52-Week High
$21.41$280.77
52-Week Low
$7.59$161.37
Typical Hold Time
16 Days15 Days
Enterprise Value
$16.35B$32.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sunrun Inc

Sunrun (RUN) trades at $7.58, down 0.39% on the day, reflecting a bearish technical trend. The stock shows attractive valuation ratios with a P/E of 5.16 and P/S of 0.59, while recent quarterly earnings have consistently beaten expectations. However, cash flow from operations remains negative, and the company faces headwinds from high borrowing costs impacting the solar sector. Positive developments include a record 580 MW grid dispatch with Tesla and expanded partnerships for distributed computing.

The outlook is mixed: strong analyst support with a $16.33 price target suggests significant upside, but operational cash burn and sector volatility pose risks. Investors should weigh low valuations against execution challenges and macroeconomic pressures affecting solar financing.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $261.07, up 0.48% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 82.83% gross margins and consistent earnings beats, while trading at attractive valuations including a 10.07 P/E ratio. Recent news highlights upcoming Q3 2026 earnings on October 29th and positive coverage of the company's growth prospects despite surgical volume challenges.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $283.36 consensus target offering 8.5% upside. The healthcare provider shows improving profitability with net margins expected to reach 9.89% in 2026. Key risks include capital allocation sustainability and potential volatility around upcoming earnings, but the combination of value pricing and growth momentum supports a positive outlook.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RUN
0% Buy100% Sell
Avg holding period · 16 Days
THC

No sentiment data available yet.

About Sunrun Inc

Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.

Read more on RUN →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →